TITLE

Putting induced pluripotent stem cells to the test

AUTHOR(S)
Vallier, Ludovic
PUB. DATE
November 2015
SOURCE
Nature Biotechnology;Nov2015, Vol. 33 Issue 11, p1145
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the sustainability of Human induced pluripotent stem cells (hiPSCs) for supporting clinical applications. Topics discussed include new possibilities for personalized cell therapy after the discovery that human somatic cell can be reprogrammed into a pluripotent stem cell, conclusive proof of the equivalence of hiPSCs and human embryonic stem cells (hESCs) by researcher Hochedlinger and colleagues and the quality of differentiated cells derived from hiPSCs.
ACCESSION #
110800595

 

Related Articles

  • Session 53: Are human embryonic stem cells ready for regenerative medicine?  // Human Reproduction;Jun2013, Vol. 28 Issue suppl_1, pi84 

    No abstract available.

  • The fate of cell reprogramming. Karagiannis, Peter; Yamanaka, Shinya // Nature Methods;Oct2014, Vol. 11 Issue 10, p1006 

    The article presents the authors' opinion on cell reprogramming and the ability to convert somatic cells to induced pluripotent stem cells which has potential to further understanding of development and disease mechanisms, as well as for cellular therapy. The authors say researchers must expand...

  • In Vitro Modeling of Paraxial Mesodermal Progenitors Derived from Induced Pluripotent Stem Cells. Sakurai, Hidetoshi; Sakaguchi, Yasuko; Shoji, Emi; Nishino, Tokiko; Maki, Izumi; Sakai, Hiroshi; Hanaoka, Kazunori; Kakizuka, Akira; Sehara-Fujisawa, Atsuko // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Induced pluripotent stem (iPS) cells are generated from adult somatic cells by transduction of defined factors. Given their unlimited proliferation and differentiation potential, iPS cells represent promising sources for cell therapy and tools for research and drug discovery. However, systems...

  • Challenges in the clinical application of induced pluripotent stem cells. Sipp, Douglas // Stem Cell Research & Therapy;2010, Vol. 1 Issue 1, p1 

    The advent of human induced pluripotent stem cells has been heralded as a major breakthrough in the study of pluripotent stem cells, for these cells have yielded fundamental insights into the reprogrammability of somatic cell fates, but also because of their seemingly great promise in...

  • SWI/SNF Chromatin Remodeling Complex: A New Cofactor in Reprogramming. He, Ling; Liu, Huan; Tang, Liling // Stem Cell Reviews & Reports;Mar2012, Vol. 8 Issue 1, p128 

    Induced pluripotent stem (iPS) cells can be derived from somatic cells. Four key factors are required in this process including Oct4, Sox2, Klf4 and c-Myc. Ectopic expression of these four factors in somatic cells leads to reprogramming. Recent studies show that the SWItch/Sucrose NonFermentable...

  • Experimental approaches for the generation of induced pluripotent stem cells. Sommer, Cesar A.; Mostoslavsky, Gustavo // Stem Cell Research & Therapy;2010, Vol. 1 Issue 3, p1 

    Derivation of autologous induced pluripotent stem cells (iPSCs) through direct reprogramming of easily accessible somatic cells holds the potential to transform the field of regenerative medicine. Since Takahashi and Yamanaka's groundbreaking study describing the generation of iPSCs by...

  • Pushing the Reset Button: Chemical-Induced Conversion of Amniotic Fluid Stem Cells Into a Pluripotent State. Diecke, Sebastian; Wu, Joseph C // Molecular Therapy;Oct2012, Vol. 20 Issue 10, p1839 

    The authors discuss the study on the factor-free derivation of a pluripotent cell type using a c-Kit+ subpopulation of human amniotic fluid cells. The authors say that the potential of human embryonic stem cells (hESC) to differentiate into any cell type of the human body has raised the hope on...

  • Investigating cellular identity and manipulating cell fate using induced pluripotent stem cells. Tohru Sugawara; Koichiro Nishino; Akihiro Umezawa; Hidenori Akutsu // Stem Cell Research & Therapy;2012, Vol. 3 Issue 2, p1 

    Induced pluripotent stem (iPS) cells, obtained from reprogramming somatic cells by ectopic expression of a defined set of transcription factors or chemicals, are expected to be used as differentiated cells for drug screening or evaluations of drug toxicity and cell replacement therapies. As...

  • Induced pluripotent stem cells in research and therapy. Hoon-Koon Teoh; Soon-Keng Cheong // Malaysian Journal of Pathology;Jun2012, Vol. 34 Issue 1, p1 

    Induced pluripotent stem cells (iPSC) are derived from human somatic cells through ectopic expression of transcription factors. This landmark discovery has been considered as a major development towards patient-specific iPSC for various biomedical applications. Unlimited self renewal capacity,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics